Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ALKBH1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101928623 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ISG20 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ACOX1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RRAS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IDH3B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OASL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MAGEA10 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DDX58 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HTRA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARPC3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PQBP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CYLD - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DESI1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PITRM1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PAAF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EIF4E2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CYB561D2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC101060521 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on